Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Ashrafzadeh-Kian

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Biochemistry|April 16, 2022
Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancySusan Ashrafzadeh-Kian, Joshua Bornhorst, Alicia Algeciras-Schimnich
American Journal of Clinical Pathology|October 19, 2021
Insulin-Like Growth Factor 1 in the Early Postoperative Assessment of AcromegalyDiane Donegan, Alicia Algeciras-Schimnich, Susan Ashrafzadeh-Kian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDaniel Figdore, Susan Ashrafzadeh-Kian, Joshua A Bornhorst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 29, 2025
False positive plasma p-tau217 results associated with heterophilic antibody interference: A potential clinical pitfallAlicia Algeciras-Schimnich, J Paul Theobald, Daniel J Figdore, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 10, 2023
Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic DisordersPaola Ramos, Bethany Larson, Susan Ashrafzadeh-Kian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 1, 2025
Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratiosDaniel J Figdore, Bethany J Schuder, Susan Ashrafzadeh-Kian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Head-to-head comparison of four plasma neurofilament light chain (NfL) immunoassaysSusan Ashrafzadeh-Kian, Daniel Figdore, Bethany Larson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSusan Ashrafzadeh-Kian, Joshua A Bornhorst, Daniel Figdore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAlicia Algeciras-Schimnich, Susan Ashrafzadeh-Kian, Joshua A Bornhorst, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Biochemistry|April 16, 2022
Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancySusan Ashrafzadeh-Kian, Joshua Bornhorst, Alicia Algeciras-Schimnich
American Journal of Clinical Pathology|October 19, 2021
Insulin-Like Growth Factor 1 in the Early Postoperative Assessment of AcromegalyDiane Donegan, Alicia Algeciras-Schimnich, Susan Ashrafzadeh-Kian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDaniel Figdore, Susan Ashrafzadeh-Kian, Joshua A Bornhorst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 29, 2025
False positive plasma p-tau217 results associated with heterophilic antibody interference: A potential clinical pitfallAlicia Algeciras-Schimnich, J Paul Theobald, Daniel J Figdore, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 10, 2023
Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic DisordersPaola Ramos, Bethany Larson, Susan Ashrafzadeh-Kian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 1, 2025
Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratiosDaniel J Figdore, Bethany J Schuder, Susan Ashrafzadeh-Kian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Head-to-head comparison of four plasma neurofilament light chain (NfL) immunoassaysSusan Ashrafzadeh-Kian, Daniel Figdore, Bethany Larson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSusan Ashrafzadeh-Kian, Joshua A Bornhorst, Daniel Figdore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAlicia Algeciras-Schimnich, Susan Ashrafzadeh-Kian, Joshua A Bornhorst, et al.
Pageof 2